Research Spotlight: A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer Abstract:Abstract 9075: Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab+carboplatin+nab-paclitaxel (A+CnP)This research was presented at the 2023 ASCO Annual Meeting. View all abstracts on asco.org Liquid Biopsy ctDNA May 26, 2023